Offshore refresher: live and learn

PSA’s Offshore Refresher Conference this year took members to Europe. ECP Sinead Stone MPS went along, courtesy of a grant from Bayer. It was...

Gut fermentation of dietary fibres: implications for health

Studies have demonstrated a link between low levels of dietary fibre and the occurrence of chronic diseases including type 2 diabetes and cardiovascular disease.

Q&A: ‘I’m going overseas tomorrow . . . can you witness...

While pharmacists are now (very) familiar with rapid antigen tests (RATs) for COVID-19 testing, the practice of observed RATs for the purpose of international...

Call for pharmacist access to the MBS for Chronic Disease Management

Pharmacists within general practice is a positive step forward, but the exclusion from MBS Team Care arrangements in CDM items makes no sense. After a...

PSA’s projects make a bigger impact than ever before

The PSA released its 2025 Strategic Projects Impact Report last week, showcasing its leadership in advancing pharmacist practice.

Treating hypertension – a new approach

Hypertension is the leading cause of cardiovascular disease, affecting 1.13 billion people worldwide, including six million adult Australians. Research has indicated that a new pharmacological...